News
Research positions Nordic Bioscience’s PRO-C6 as next-generation biomarker
Nordic Bioscience has announced that the New England Journal of Medicine Evidence (NEJME) has published research that further establishes its extracellular matrix biomarker, PRO-C6, as a potential next-generation biomarker.